Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RuMCeSS: MSCs in Septic Shock and Severe Neutropenia
NCT01849237Phase 2Unknown
- Sponsor
- National Medical Research Center for Hematology
- Start
- Dec 2012
- Primary completion
- Apr 2013
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of Provacel in septic shock, sponsored by National Medical Research Center for Hematology. Status: unknown.
02
Drugs
Provacel
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT01849237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01849237.